Chu Dong-Xia, Jin Yu, Wang Bing-Rong, Jiao Yan, Zhang Chao-Ke, Guo Zi-Han, Hu Shao-Zhuo, Li Na
Department of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, 130021, P.R. China.
Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin, 130021, P.R. China.
J Cancer. 2023 Jul 24;14(12):2329-2343. doi: 10.7150/jca.85335. eCollection 2023.
LncRNA HOTAIR play important roles in the epigenetic regulation of carcinogenesis and progression in liver cancer. Previous studies suggest that the overexpression of HOTAIR predicts poor prognosis. In this study, through transcriptome sequencing data and experiments, we found that HOTAIR were more highly expressed and there is significantly positive relationship between HOTAIR and NUAK1 in liver cancer tissues and cell lines. miR-145-5p was downregulated and showed negative correlation with HOTAIR and NUAK1. Transfect Sh-HOTAIR, LZRS-HOTAIR, miR-145 mimic, miR-145 inhibitor to change the expression of HOTAIR and miR-145-5p. The addition of HTH-01-015 inhibits the expression of NUAK1. HOTAIR knockdown, miR-145-5p upregulation and NUAK1 inhibition all repressed migration, invasion and metastasis and reversed the epithelial-to-mesenchymal transition in SNU-387 and HepG2 cells. We also showed that HOTAIR recruiting and binding PRC2 (EZH2) epigenetically represses miR-145-5p, which controls the target NUAK1, thus contributing to liver cancer cell-EMT process and accelerating tumor metastasis. Moreover, it is demonstrated that HOTAIR crosstalk with miR-145-5p/NUAK1 during epigenetic regulation. Our findings indicate that HOTAIR/miR-145-5p/NUAK1 axis acts as an EMT regulator and may be candidate prognostic biomarker and targets for new therapies in liver cancer.
长链非编码RNA HOTAIR在肝癌发生和进展的表观遗传调控中发挥重要作用。先前的研究表明,HOTAIR的过表达预示着预后不良。在本研究中,通过转录组测序数据和实验,我们发现HOTAIR在肝癌组织和细胞系中表达更高,且HOTAIR与NUAK1之间存在显著正相关。miR-145-5p表达下调,且与HOTAIR和NUAK1呈负相关。转染Sh-HOTAIR、LZRS-HOTAIR、miR-145模拟物、miR-145抑制剂以改变HOTAIR和miR-145-5p的表达。添加HTH-01-015可抑制NUAK1的表达。HOTAIR敲低、miR-145-5p上调和NUAK1抑制均抑制了SNU-387和HepG2细胞的迁移、侵袭和转移,并逆转了上皮-间质转化。我们还表明,HOTAIR招募并结合PRC2(EZH2),通过表观遗传方式抑制miR-145-5p,而miR-145-5p控制靶标NUAK1,从而促进肝癌细胞的上皮-间质转化过程并加速肿瘤转移。此外,证明了HOTAIR在表观遗传调控过程中与miR-145-5p/NUAK1相互作用。我们的研究结果表明,HOTAIR/miR-145-5p/NUAK1轴作为一种上皮-间质转化调节因子,可能是肝癌预后生物标志物候选物和新治疗靶点。